The miRNAs along with other ncRNAs significantly reverse the BC cell drug resistance by suppressing signaling pathways such as Wnt/β-catenin, Hippo, AKT, TGF-β, or mTOR signaling pathways. This evidence concerns the gene AKT1 and breast cancer.